1.

EUCAST en Belgique. Introduction des nouveaux critères d'interprétation de l'Antibiogramme: Pourquoi, Quand, Difficultés et solutions

1.

Distribution of serotypes of clinical group B streptococci isolated in Belgium: a decade review

2.

Distribution of serotypes of clinical group B streptococci isolated in Belgium: a decade review

3.

Distribution of serotypes of clinical group B streptococci isolated in Belgium: a decade review

1.

Hereditary angioedema (HAE) in Belgium: results from a national survey

2.

Hereditary angioedema (HAE) in Belgium: results from a national survey

3.

Hereditary angioedema (HAE) in Belgium: results from a national survey

1.

A case of hepatic alveolar echinococcosis contracted in Belgium

1.

Endemic alveolar echinococcosis in southern Belgium?

1.

Alveolar echinococcosis is increasing in Southern Belgium: a report of the Belgian National Reference Laboratory for Echinococcosis (BNRLE) and clinical experience of ECHINO- Liege

2.

Alveolar echinococcosis is increasing in Southern Belgium: a report of the Belgian National Reference Laboratory for Echinococcosis (BNRLE) and clinical experience of ECHINO- Liege

3.

Alveolar echinococcosis is increasing in Southern Belgium: a report of the Belgian National Reference Laboratory for Echinococcosis (BNRLE) and clinical experience of ECHINO- Liege

1.

Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.

1.

Surveillance of antimicrobial resistance in Streptococcus agalactiae isolated from patients in Belgium (1989-1991 versus 1996-1999)

2.

Surveillance of antimicrobial resistance in Streptococcus agalactiae isolated from patients in Belgium (1989-1991 versus 1996-1999)

3.

Surveillance of antimicrobial resistance in Streptococcus agalactiae isolated from patients in Belgium (1989-1991 versus 1996-1999)

1.

Evolution of antimicrobial susceptibility patterns of clinical group B streptococci isolated in Belgium

2.

Evolution of antimicrobial susceptibility patterns of clinical group B streptococci isolated in Belgium

3.

Evolution of antimicrobial susceptibility patterns of clinical group B streptococci isolated in Belgium

1.

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.